VIR BIOTECHNOLOGY INC (VIR) — institutional ownership
260 funds reported holding VIR BIOTECHNOLOGY INC in their latest 13F filings, worth $1.58B in total (CUSIP 92764N102).
Largest holders
- BlackRock, Inc. (BLK) — $211M
- ARCH Venture Management, LLC — $129M
- VANGUARD PORTFOLIO MANAGEMENT LLC — $117M
- SB INVESTMENT ADVISERS (UK) LTD — $112M
- STATE STREET CORP (STT, STT-PG) — $102M
- GSK plc (GSK, GLAXF) — $87.1M
- VANGUARD GROUP INC — $75.7M
- VANGUARD CAPITAL MANAGEMENT LLC — $65.1M
- Point72 Asset Management, L.P. — $57.7M
- GEODE CAPITAL MANAGEMENT, LLC — $34.1M
Famous investors holding it
- Two Sigma portfolio (Two Sigma Investments)
- Ken Griffin portfolio (Citadel Advisors)
- Renaissance Technologies portfolio (Renaissance Technologies)
- D. E. Shaw portfolio (D. E. Shaw & Co.)
- Izzy Englander portfolio (Millennium Management)